Cargando…

The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy – 5-year follow-up

BACKGROUND: We assessed the influence of atorvastatin on selected indicators of an inflammatory condition, left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy (DCM). METHODS: We included 68 DCM patients with left ventricular ejection fraction (LVEF) ≤40%...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bielecka-Dabrowa, Agata, Mikhailidis, Dimitri P, Rizzo, Manfredi, von Haehling, Stephan, Rysz, Jacek, Banach, Maciej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641983/ https://www.ncbi.nlm.nih.gov/pubmed/23566246 http://dx.doi.org/10.1186/1476-511X-12-47

Ejemplares similares

Influence of co-existing atrial fibrillation on the efficacy of atorvastatin treatment in patients with dilated cardiomyopathy: a pilot study
por: Bielecka-Dąbrowa, Agata, et al.
Publicado: (2010)

The mechanisms of atrial fibrillation in hyperthyroidism
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2009)

Arterial Stiffness and Indices of Left Ventricular Diastolic Dysfunction in Patients with Embolic Stroke of Undetermined Etiology
por: Gąsiorek, Paulina, et al.
Publicado: (2019)

Correction to: Association of statin use and clinical outcomes in heart failure patients: a systematic review and meta-analysis
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2020)

Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview
por: Michalska-Kasiczak, Marta, et al.
Publicado: (2018)

Biomarkers and Echocardiographic Predictors of Myocardial Dysfunction in Patients with Hypertension
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2015)

Malignancy-Associated Dyslipidemia
por: Bielecka-Dąbrowa, Agata, et al.
Publicado: (2011)

The Rise and Fall of Hypertension: Lessons Learned from Eastern Europe
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2011)

Association of statin use and clinical outcomes in heart failure patients: a systematic review and meta-analysis
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2019)

Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications
por: Bikiewicz, Agata, et al.
Publicado: (2021)

Left Ventricular Diastolic Dysfunction as Predictor of Unfavorable Prognosis After ESUS
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2021)

Diagnostic Usefulness of Spiroergometry and Risk Factors of Long COVID in Patients with Normal Left Ventricular Ejection Fraction
por: Gryglewska-Wawrzak, Katarzyna, et al.
Publicado: (2023)

Factors of Persistent Limited Exercise Tolerance in Patients after COVID-19 with Normal Left Ventricular Ejection Fraction
por: Gryglewska-Wawrzak, Katarzyna, et al.
Publicado: (2022)

Factors and Prognostic Significance of Impaired Exercise Tolerance in Women over 40 with Arterial Hypertension
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2021)

The profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2017)

The Multi-Biomarker Approach for Heart Failure in Patients with Hypertension
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2015)

Established and potential echocardiographic markers of embolism and their therapeutic implications in patients with ischemic stroke
por: Gąsiorek, Paulina E., et al.
Publicado: (2019)

The role of nutraceuticals in heart failure muscle wasting as a result of inflammatory activity. The International Lipid Expert Panel (ILEP) Position Paper
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2023)

Erythropoietin update 2011
por: Kowalczyk, Mariusz, et al.
Publicado: (2011)

The outcomes of hypertension treatment depending on gender in patients over 40 years of age
por: Paduszyńska, Aleksandra, et al.
Publicado: (2021)

Cardioprotective properties of leptin in patients with excessive body mass
por: Paduszyńska, Aleksandra, et al.
Publicado: (2020)

Lipid-lowering therapies and achievement of LDL-cholesterol targets
por: Rizzo, Manfredi, et al.
Publicado: (2012)

Role of confirmed and potential predictors of an unfavorable outcome in heart failure in everyday clinical practice
por: Chuda, Anna, et al.
Publicado: (2021)

Heart Failure Risk Predictions and Prognostic Factors in Adults With Congenital Heart Diseases
por: Leczycki, Patryk, et al.
Publicado: (2022)

Effects of Implementing Personalized Health Education in Ambulatory Care on Cardiovascular Risk Factors, Compliance and Satisfaction with Treatment
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2022)

The Relationship of Dehydration and Body Mass Index With the Occurrence of Atrial Fibrillation in Heart Failure Patients
por: Chuda, Anna, et al.
Publicado: (2021)

Menopause and women’s cardiovascular health: is it really an obvious relationship?
por: Ryczkowska, Kamila, et al.
Publicado: (2022)

Obesity and Body Mass Components Influence Exercise Tolerance and the Course of Hypertension in Perimenopausal Women
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2022)

Evaluation of left ventricular strain in patients with dilated cardiomyopathy
por: Yu, Yaohan, et al.
Publicado: (2017)

The Role of Multidisciplinary Approaches in the Treatment of Patients with Heart Failure and Coagulopathy of COVID-19
por: Gryglewska-Wawrzak, Katarzyna, et al.
Publicado: (2023)

Arrhythmogenic Right Ventricular Cardiomyopathy: Characterization of Left Ventricular Phenotype and Differential Diagnosis With Dilated Cardiomyopathy
por: Cipriani, Alberto, et al.
Publicado: (2020)

Left ventricular strain echocardiography in advanced uremic cardiomyopathy compared to dilated cardiomyopathy
por: Mohammadi, Rizan, et al.
Publicado: (2023)

A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations
por: Serban, Corina, et al.
Publicado: (2015)

Predictors of Long COVID in Patients without Comorbidities: Data from the Polish Long-COVID Cardiovascular (PoLoCOV-CVD) Study
por: Chudzik, Michał, et al.
Publicado: (2022)

Decreased Left Ventricular Torsion and Untwisting in Children with Dilated Cardiomyopathy
por: Jin, Seon Mi, et al.
Publicado: (2007)

Left ventricular hemodynamic forces are altered in patients with dilated cardiomyopathy
por: Eriksson, Jonatan, et al.
Publicado: (2015)

Changes in the Left Ventricular Eicosanoid Profile in Human Dilated Cardiomyopathy
por: Sosnowski, Deanna K., et al.
Publicado: (2022)

Patient after correction Taussig‐Bing anomaly with severe neo‐aortic regurgitation after sudden cardiac arrest
por: Bielecka‐Dabrowa, Agata, et al.
Publicado: (2021)

The appropriate dose of angiotensin‐converting‐enzyme inhibitors or angiotensin receptor blockers in patients with dilated cardiomyopathy. The higher, the better?
por: Ishida, Junichi, et al.
Publicado: (2015)

Left Ventricular Global Longitudinal Strain as a Predictor for Left Ventricular Reverse Remodeling in Dilated Cardiomyopathy
por: Jung, In Hyun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b52se013hpnc1n1aim0ok5a88m